Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostaglandin E1 improves endothelial function in critical limb ischemia.

Simona Marchesi1, Leonella Pasqualini, Rita Lombardini

  • 1Unit of Internal Medicine, Angiology and Arteriosclerosis, University of Perugia Medical School, via Brunacci Brunamonti, 51 IT-06122 Perugia, Italy. simonamarchesi@yahoo.it

Journal of Cardiovascular Pharmacology
|January 28, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and Biological Implications of TP53 Abnormalities in Relapsed/Refractory Multiple Myeloma: The DEDALO Study.

Clinical lymphoma, myeloma & leukemia·2026
Same author

Platelets from COVID-19 Patients Show an Altered Nitric Oxide/Reactive Oxygen Species Production Balance.

Thrombosis and haemostasis·2025
Same author

Association of human leucocyte antigen loci with vaccine-induced immune thrombotic thrombocytopenia: Potential role of the interaction between platelet factor 4-derived peptides and MHC-II.

British journal of haematology·2024
Same author

The Healthy Fatty Index Allows for Deeper Insights into the Lipid Composition of Foods of Animal Origin When Compared with the Atherogenic and Thrombogenicity Indexes.

Foods (Basel, Switzerland)·2024
Same author

Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry.

Clinics and practice·2023
Same author

Exosomal miR-17-5p, miR-146a-3p, and miR-223-3p Correlate with Radiologic Sequelae in Survivors of COVID-19-Related Acute Respiratory Distress Syndrome.

International journal of molecular sciences·2023

Prostaglandin E1 (PGE1) treatment significantly improved endothelial function in critical limb ischemia patients. This therapy reduced adhesion molecules and enhanced brachial artery vasodilation, offering a potential new treatment avenue.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Pharmacology

Background:

  • Critical limb ischemia (CLI) is characterized by impaired endothelial function and elevated levels of soluble adhesion molecules.
  • Prostaglandin E1 (PGE1) is known to alleviate CLI symptoms, but its precise mechanism on endothelial function requires further elucidation.

Purpose of the Study:

  • To investigate the effects of Prostaglandin E1 (PGE1) on endothelial function, specifically brachial artery flow-mediated vasodilation (FMV).
  • To assess the impact of PGE1 on plasma levels of soluble adhesion molecules, including vascular adhesion molecule-1 (sVCAM-1) and intercellular adhesion molecule-1 (sICAM-1) in CLI patients.

Main Methods:

  • A study involving 12 patients with critical limb ischemia treated with daily intravenous PGE1 infusions (alprostadil 60 microg) for two weeks.

Related Experiment Videos

  • Measurements of FMV, sICAM-1, and sVCAM-1 were conducted at baseline, after the first infusion, and at one and two weeks of treatment.
  • Comparison of patient data with 30 healthy control subjects.

    • Main Results:

    • Patients with CLI exhibited significantly higher baseline sVCAM-1 and sICAM-1 levels and lower FMV compared to healthy controls.
    • PGE1 treatment led to a progressive decrease in sICAM-1 levels and a significant reduction in sVCAM-1 after two weeks.
    • Brachial artery flow-mediated vasodilation (FMV) showed significant improvement after one and two weeks of PGE1 therapy.

    Conclusions:

    • Treatment with Prostaglandin E1 (PGE1) significantly enhances endothelial function in patients suffering from critical limb ischemia.
    • PGE1 therapy effectively reduces circulating levels of key adhesion molecules (sICAM-1 and sVCAM-1) in CLI patients.
    • The findings suggest PGE1 improves vascular health by modulating endothelial function and reducing inflammatory markers in CLI.